Bleichroeder’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.48M Hold
254,753
– – 0.15% 67
2026
Q2
$1.69M Hold
254,753
– – 0.3% 37
2026
Q1
$1.65M Hold
254,753
– – 0.29% 33
2025
Q4
$2M Buy
254,753
+71,420
+39% +$459K 0.35% 29
2025
Q3
$896K Hold
183,333
– – 0.17% 37
2025
Q2
$1.08M Hold
183,333
– – 0.27% 31
2025
Q1
$1.07M Hold
183,333
– – 0.28% 26
2024
Q4
$1.38M Buy
183,333
+50,000
+38% +$384K 0.35% 29
2024
Q3
$1.06M Hold
133,333
– – 0.29% 32
2024
Q2
$1.12M Hold
133,333
– – 0.33% 30
2024
Q1
$1.14M Hold
133,333
– – 0.28% 31
2023
Q4
$1.13M Buy
+133,333
New +$1.27M 0.25% 29

Other funds holding PROF

Bleichroeder's PROF Position: Q3 2026 in Review

Bleichroeder held its Profound Medical (PROF) position steady in Q3 2026 at 254,753 shares worth $1.48M. The position accounts for 0.15% of the portfolio, ranked #67.

Bleichroeder first reported a position in PROF in Q4 2023 and has held it in 12 quarters since. The position peaked at $2M in Q4 2025. 43 funds tracked by Wall St. Rank hold PROF as of Q3 2026.

  • Bleichroeder held 254,753 shares of Profound Medical worth $1.48M as of Q3 2026.
  • Bleichroeder left its Profound Medical share count unchanged in Q3 2026.
  • Profound Medical made up 0.15% of Bleichroeder's portfolio in Q3 2026, its #67 holding.
  • Bleichroeder first reported a position in Profound Medical in Q4 2023 and has held it in 12 quarters since.
  • Bleichroeder's Profound Medical position peaked at $2M in Q4 2025.
  • 43 funds tracked by Wall St. Rank held Profound Medical as of Q3 2026.

Based on Bleichroeder's 13F filing for Q3 2026, filed 13 Nov 2026.